OlyCAR-019
/ 920th Hospital of Joint Logistics Support Force of the Chinese People's Liberation Army
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 06, 2023
A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies
(clinicaltrials.gov)
- P1/2 | N=60 | Recruiting | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
New P1/2 trial • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1